Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

      research-article
      1 , , 2 , 1 , 3 , 4 , 5 , 1 , 6 , 5 , 7 , 8 , 9 , 8 , 10 , 10 , 11 , 12 , 12 , 13 , 14 , 14 , 14 , 15 , 15 , 16 , 17 , 17 , 18 , 19 , 20 , 21 , 22 , 22 , 23 , 9 , 6 , 24 , 25 , 26 , 26 , 27 , 27 , 28 , 28 , 29 , 30 , 30
      Rheumatology (Oxford, England)
      Oxford University Press
      Systemic sclerosis, Scleroderma, Connective tissue disease, Overlap syndrome, Undifferentiated disease

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective. Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the detection and follow-up of patients presenting with different disease manifestations, an interdisciplinary registry was founded with contributions from different subspecialties involved in the care of patients with SSc.

          Methods. A questionnaire was developed to collect a core set of clinical data to determine the current disease status. Patients were grouped into five descriptive disease subsets, i.e. lcSSc, dcSSc, SSc sine scleroderma, overlap-syndrome and UCTD with scleroderma features.

          Results. Of the 1483 patients, 45.5% of patients had lcSSc and 32.7% dcSSc. Overlap syndrome was diagnosed in 10.9% of patients, while 8.8% had an undifferentiated form. SSc sine scleroderma was present in 1.5% of patients. Organ involvement was markedly different between subsets; pulmonary fibrosis for instance was significantly more frequent in dcSSc (56.1%) than in overlap syndrome (30.6%) or lcSSc (20.8%). Pulmonary hypertension was more common in dcSSc (18.5%) compared with lcSSc (14.9%), overlap syndrome (8.2%) and undifferentiated disease (4.1%). Musculoskeletal involvement was typical for overlap syndromes (67.6%). A family history of rheumatic disease was reported in 17.2% of patients and was associated with early disease onset ( P < 0.005).

          Conclusion. In this nationwide register, a descriptive classification of patients with disease manifestations characteristic of SSc in five groups allows to include a broader spectrum of patients with features of SSc.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Criteria for the classification of early systemic sclerosis.

          We propose criteria for the early diagnosis and classification of systemic sclerosis that reflect the vascular and serological advances of the last 2 decades.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

            Assessment of the inter and intraobserver variability of the modified Rodnan (m-Rodnan) total skin thickness score by clinical palpation [a commonly used outcome measure in trials of systemic sclerosis (SSc)]. Skin thickness was assessed by clinical palpation of 17 body areas on 0 to 3 scale (normal, mild, moderate, severe). The m-Rodnan total skin thickness score was derived by summation of the scores from all 17 body areas. Using the m-Rodnan, 6-7 investigators assessed skin thickness in 5-6 patients with SSc (22 patients and 23 examiners total) at each of 4 sessions for the determination of interobserver variability (accuracy). In addition 21 of the investigators then assessed m-Rodnan in 2-3 patients each (60 patients total) 3 times over a 2-8 week period to quantitate intraobserver variability (reliability). Interobserver and intraobserver mean +/- within patient standard deviations (SD) for the m-Rodnan were found to be 17.7 +/- 4.6 and 20.7 +/- 2.45, respectively. The m-Rodnan total skin thickness score is at least as reliable for measuring skin thickness in SSc as are the ARA and Ritchie joint tenderness counts for assessing joint disease in rheumatoid arthritis. These data are useful for the determination of sample size and for the definitions of clinically meaningful response. Assessment of skin score is sufficiently reproducible to include as a measure of disease outcome, especially if patients are serially evaluated by the same investigator.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Scleroderma epidemiology.

              Evidence from multiple sources indicates that SSc does not occur randomly in the population; there are particular groups who are at greater risk. The overall incidence rate of SSc in the adult population of the United States is approximately 20 per million per year; this rate has increased from 1944 to 1973, but has been relatively stable since that time. The prevalence of SSc in the United States also seems to be stable over the past two decades with a prevalence estimate for adults of 240 per million. Recent population studies suggest that SSc occurs more frequently in the United States than in continental Europe, the United Kingdom, and in some areas in Asia. Overall survival has improved over the past few decades; mean survival is approximately 12 years from diagnosis. Renal disease accounts for some of the early mortality, but pulmonary disease has emerged as a major cause of death. Cardiac disease is also correlated with a poorer prognosis. Gastrointestinal involvement contributes to morbidity and, indirectly, to mortality, but the magnitude of this contribution is difficult to assess. Women are affected more frequently than men but the factors that are responsible for this are not apparent. Studies of reproductive history have provided conflicting data; some studies suggested that the number of pregnancies may influence later disease expression, whereas other studies found no correlation. Racial factors seem to play a role in disease susceptibility, as well as disease expression. Age-specific incidence rates are higher in black women than in white women; the greatest difference occurs in the young to middle adult age group (less than 54 years of age). Diffuse disease also seems to occur more commonly in the black population than in the white. Age at onset of diffuse disease is younger, on average, than the age at onset of limited disease; age-adjusted survival is worse in black women than in white women because of their predilection for diffuse disease. Reports of geographic clustering are intriguing; the reported clusters in London and Italy have not resulted in the identification of potential causal factors. The Choctaw Native American cluster suggests that genetic factors that have not been identified may play an important role. Familial clustering of SSc has been demonstrated in the United States and in Australia, which provides additional evidence of a genetic component. It is likely that there is a strong interplay among genetic factors, hormonal or reproductive-related events, and an external trigger that must interact to result in clinical disease.
                Bookmark

                Author and article information

                Journal
                Rheumatology (Oxford)
                brheum
                rheumatology
                Rheumatology (Oxford, England)
                Oxford University Press
                1462-0324
                1462-0332
                August 2008
                31 May 2008
                31 May 2008
                : 47
                : 8
                : 1185-1192
                Affiliations
                1Department of Dermatology and Venerology, University of Cologne, Cologne, 2Department of Rheumatology, University of Aachen, Aachen, 3Institute of Biostatistics, Informatics and Epidemiology, University of Cologne, Cologne, 4Clinical Research Unit for Rheumatology, University Medical Center Freiburg, Freiburg , 5Department of Dermatology, Dresden University Hospital, Dresden, 6Department of Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim, 7Rheumatology and Clinical Immunology, Charité, Berlin, 8Hospital Cologne-Merheim, Medical Clinic I, 9Department of Dermatology, University of Münster, Münster, 10Department of Dermatology, Venerology and Allergology, University Hospital Charité, Berlin, 11Department of Rheumatology, University of Cologne, Cologne, 12Department of Dermatology, University of Mainz, Mainz, 13Department of Dermatology and Allergology, University of Munich, Munich, 14Department of Dermatology and Allergology, University of Ulm, Ulm, 15Department of Dermatology, 16Department of Internal Medicine, University of Regensburg, Regensburg, 17Department of Internal Medicine, University of Regensburg, Regensburg, 18Department of Dermatology, Allergology and Environmental Medicine, Private University Witten-Herdecke, HELIOS Klinikum Wuppertal, Wuppertal, 19Hospital Eilbek, Hamburg, 20Department of Internal Medicine, University of Giessen, Giessen, 21Clinic for Rheumatology, Bad Bramstedt, 22Department of Dermatology, University of Düsseldorf, Düsseldorf, 23Department of Dermatology and Venerology,Georg-August-University of Göttingen, Göttingen, 24Department of Dermatology, University of Tübingen, Tübingen, 25Department of Internal Medicine, University of Tübingen, Tübingen, 26Department of Internal Medicine, University of Heidelberg, Heidelberg, 27Johanniter Hospital in Fläming gGmbH, Center of Rheumatology of Brandenburg, Germany, 28Department of Dermatology and Venerology, University of Graz, Graz, Austria, 29Department of Internal Medicine, Center of Rheumatology, Baden-Baden and 30Department of Dermatology, Clinic of Minden, Minden, Germany.
                Author notes
                Correspondence to: N. Hunzelmann, Department of Dermatology and Venerology, University of Cologne, Kerpener Str. 62, 50924 Cologne, Germany. E-mail: Sklerodermie-Netzwerk@ 123456uk-koeln.de
                Article
                ken179
                10.1093/rheumatology/ken179
                2468885
                18515867
                6af88443-92fe-4673-a988-c5aee393ed06
                © 2008 The Author(s)

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 November 2007
                : 2 April 2008
                Categories
                Clinical

                Rheumatology
                overlap syndrome,scleroderma,connective tissue disease,systemic sclerosis,undifferentiated disease

                Comments

                Comment on this article